Search Results - "Vassias, Antonios"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Anaphylaxis during rapid oral desensitization to rifampicin by Syrigou, Ekaterini, MD, PhD, Grapsa, Dimitra, MD, PhD, Nanou, Eugenia, MD, Zande, Maria, MD, Vassias, Antonios, MD, Gkiozos, Ioannis, MD, PhD, Syrigos, Konstantinos, MD, PhD

    “…Hypersensitivity reactions to anti-TB agents are relatively uncommon, encountered in approximately 4%-5% of the treated population, but may as well lead to…”
    Get full text
    Journal Article
  2. 2

    Biological predictors of third-line treatment outcomes in patients with advanced non-small cell lung cancer by Vassias, Antonios, Vassos, Dimitrios, Grapsa, Dimitra, Bakakos, Petros, Rovina, Nikoletta, Syrigos, Konstantinos N.

    Published in Journal of clinical oncology (20-05-2020)
    “…Abstract only e21597 Background: The introduction of molecularly-guided targeted therapies and immunotherapy in routine oncology practice has led to…”
    Get full text
    Journal Article
  3. 3

    Chemotherapy-induced neutropenia in lung cancer patients: The role of antibiotic prophylaxis by Kouranos, Vasileios, Dimopoulos, George, Vassias, Antonios, Syrigos, Kostas N

    Published in Cancer letters (26-12-2011)
    “…Highlights ► We performed a PubMed literature search of manuscripts published until May 2011. ► Quinolones and trimethoprim/sulfamethoxazole were most…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Triplet combination of carboplatin, irinotecan, and etoposide in the first-line treatment of extensive small-cell lung cancer: a single-institution phase II study by Charpidou, Andriani, Tsagouli, Sophia, Tsimpoukis, Sotirios, Vassias, Antonios, Makrilia, Nektaria, Stratakos, Grigorios, Gkiozos, Ioannis, Syrigos, Kostas

    Published in Anti-cancer drugs (01-07-2010)
    “…Small-cell lung cancer is a rapidly progressive tumor and median survival is less than 10 months in patients with extensive stage of the disease. This study…”
    Get full text
    Journal Article
  8. 8

    Administration of cisplatin in three patients with carboplatin hypersensitivity: is skin testing useful? by Syrigou, Ekaterini, Makrilia, Nektaria, Vassias, Antonios, Nikolaidis, Ilias, Xyla, Vassilia, Manolopoulos, Leonidas, Syrigos, Kostas

    Published in Anti-cancer drugs (01-03-2010)
    “…Carboplatin is a chemotherapeutic agent approved in the first-line setting of numerous malignancies. Hypersensitivity to carboplatin has been reported in up to…”
    Get full text
    Journal Article